Kezar Life Sciences Inc. (KZR) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Kezar Life Sciences Inc.

NASDAQ: KZR · Real-Time Price · USD
3.92
0.03 (0.77%)
At close: Oct 03, 2025, 3:59 PM
3.96
1.02%
After-hours: Oct 03, 2025, 05:00 PM EDT

Kezar Life Sciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
41.75M 35.49M 40.46M 62.88M
Short-Term Investments
90.5M 165.88M 236.1M 145.47M
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
2.42M 5.59M 674K 282K
Receivables
424K 2.29M n/a 70K
Inventory
n/a n/a n/a 2.5M
Other Current Assets
351K 251K 920K -1.84M
Total Current Assets
137.49M 206.95M 285.72M 211.65M
Property-Plant & Equipment
4.78M 8.69M 13.17M 6M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
7.19M 14.29M 13.85M 6.28M
Total Assets
144.68M 221.24M 299.57M 217.93M
Account Payables
3.65M 8.25M 2.48M 2.03M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
5.22M 3.01M 2.56M 1.2M
Other Current Liabilities
5.22M 802K 960K 1.82M
Total Current Liabilities
20.33M 17.74M 11M 8.21M
Long-Term Debt
5.11M 10.07M 9.83M 9.62M
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
7.44M 15.92M 18.7M 12.85M
Total Liabilities
27.77M 33.66M 29.7M 21.06M
Total Debt
16.18M 18.93M 21.26M 14.04M
Book Value
116.92M 187.57M 269.87M 196.88M
Book Value Per Share
1.60 2.59 4.01 3.73
Common Stock
7K 73K 68K 56K
Retained Earnings
-434.5M -350.76M -248.89M -180.65M
Comprehensive Income
-162K -130K -923K -291K
Shareholders Equity
116.92M 187.57M 269.87M 196.88M
Total Investments
90.5M 165.88M 236.1M 145.47M